| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000024593 |
| Receipt No. | R000028292 |
| Official scientific title of the study | Examination of the effectiveness against retinal vascular occlusion treated with retinal endovascular surgery using tissue plasminogen activator. |
| Date of disclosure of the study information | 2017/01/01 |
| Last modified on | 2016/10/27 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Examination of the effectiveness against retinal vascular occlusion treated with retinal endovascular surgery using tissue plasminogen activator. | |
| Title of the study (Brief title) | Examination of retinal endovascular surgery against retinal vascular occlusion. | |
| Region |
|
|
| Condition | ||
| Condition | retinal vein occlusion
retinal artery occlusion |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy and safety of the retinal endovascular therapy using tissue plasminogen activator against retinal vascular occlusion |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Postoperative week 1 : visual acuity, postoperative complication , Optical Coherence Tomography (OCT)
Postoperative week 4 : visual acuity, postoperative complication , OCT Postoperative week 12 : visual acuity, postoperative complication , OCT Postoperative week 24 : visual acuity, postoperative complication , OCT , fluorescein fundus angiography (FAG) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | We inject tissue plasminogen activator (t-PA, a monteplase) 5000IU into a retinal vascular used in vitreous surgery. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patient undergoing vitreous surgery and stay in hospital for about one week in our hospital.
The patient receives a sufficient explanation about vitreous surgery. The patient who we can get a patient's informed consent before conducting the treatment. |
|||
| Key exclusion criteria | We take patient's past medical history. We exclude a patient with cerebrovascular disorders and patient with a history of cerebral infarction and blood disease.
And the case is judged to be at high risk to use t-PA for patients. |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Chie Sotozono |
| Organization | Kyoto Prefectual Univercity of Medicine |
| Division name | Department of Ophthalmology |
| Address | 465 Kajii cho Hirokoji agaru Kawaramachi dori Kamigyo ku Kyoto |
| TEL | 075-251-5578 |
| csotozon@koto.kpu-m.ac.jp | |
| Public contact | |
| Name of contact person | Yoichiro Shinkai |
| Organization | Kyoto Prefectual Univercity of Medicine |
| Division name | Department of Ophthalmology |
| Address | 465 Kajii cho Hirokoji agaru Kawaramachi dori Kamigyo ku Kyoto |
| TEL | 075-251-5578 |
| Homepage URL | |
| yshinkai@koto.kpu-m.ac.jp | |
| Sponsor | |
| Institute | Kyoto Prefectual Univercity of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | the cost from Kyoto Prefectual Univercity of Medicine, Department of Ophthalmology |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028292 |